Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-21-000096 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
510.34% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.40% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
41.59% · OPTIONAL · VALID
Revenue growth 88th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.revenue
59.61% · CORE · VALID
Gross margin 25th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.gross_margin
77.90% · CORE · VALID
Operating margin 33th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.operating_margin
-24.86% · CORE · VALID
R&D intensity 83th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.21% · OPTIONAL · VALID
SBC intensity 83th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
34.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 564.93%
Current 510.34%
Delta -54.59% Capex Intensity Increased
Previous 6.69%
Current 8.40%
Delta 1.71% Cash Generation Increased
Previous 19.36%
Current 41.59%
Delta 22.23% Growth Increased
Previous 55.08%
Current 59.61%
Delta 4.53% Margin Decreased
Previous 78.26%
Current 77.90%
Delta -0.36% Profitability Increased
Previous -34.32%
Current -24.86%
Delta 9.46% R And D Intensity Decreased
Previous 26.59%
Current 23.21%
Delta -3.37% Sbc Intensity Decreased
Previous 39.08%
Current 34.00%
Delta -5.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.